Syncom Formulations (India) Limited

Pharmaceuticals|Pharmaceuticals

SYNCOMF-EQ: NSEBSE: 11992

Syncom Formulations (India) Limited (SYNCOMF-EQ) live share price today at NSE / BSE

INR 18.78

+0.37 (2.01%)1 Day

Thu, 17 Sept 2026, 01:41 PM

About SYNCOMF-EQ

Syncom Formulations (India) Ltd is an Indian pharmaceutical company engaged in the development, manufacturing, and marketing of a broad range of healthcare formulations. Established in 1988 and headquartered in Mumbai, Syncom operates with a focus on both domestic and international pharmaceutical markets, serving over 20 countries across Africa, Southeast Asia, Latin America, and the CIS region. The company specializes in producing affordable, high-quality medicines, including tablets, capsules, oral liquids, ointments, and syrups, complemented by a diverse portfolio of allopathic and herbal products.

52 Week Range

HighINR 22.59

LowINR 10.21

Current Signal

red

Open

INR 18.40

High

INR 19.05

Low

INR 18.16

Prev. Close

INR 18.41

Volume

51,34,221

Avg. Volume (7D)

90,78,928

Avg. Volume (10D)

1,10,30,549

Latest Signal

Sell

Sell Price

INR 20.0

Close Price

INR 19.26

Change

16.95%

Signal Date

2026-09-10

Hold

Pattern

Bullish Engulfing

Company Snapshot

CIN	L24239MH1988PLC047759
Industry	Pharmaceuticals
Market Lot	1
Impact Cost	0.21%
Listing Date	17 Apr 1994
BC Record Date	BC 24/09/2024-30/09/2024
Registered Address	7, Niraj Industrial Estate, Off Mahakali Caves Road, Andheri (E)
Auditor	Sanjay Mehta and Associates

Registrar

Name

Ankit Consultancy Pvt. Ltd

Telephone

0731 - 4065799, 4065797

Website

www.ankitonline.com

Shareholding Pattern

Quarterly filing · 30 Jun 2026

Promoter & Promoter Group50.57%

Non-Institutions50.09%

Board of Directors

Mr.Ankit JainNon-Executive - Independent Director

Mr.Ankit Kedarmal BankdaChairperson & Executive Director

Mr.Kedarmal Shankarlal BankdaWhole Time Director

Mr.Rahul Vijay BankdaChief Financial Officer

Mr.Ritesh Kumar LunkadNon-Executive - Independent Director

Mr.Vijay Shankarlal BankdaExecutive Director-MD

Mrs.Ruchi JindalNon-Executive - Independent Director

Ms.Vaishali AgrawalCompany Secretary & Compliance Officer

Today Share Price

Syncom Formulations (India) Limited

Particulars	Details
Opening Price	INR 18.40
Previous Closing Price	INR 18.41
Volume of Syncom Formulations (India) Limited	51,34,221
Value of Share	—

Today NSE Share Price

Syncom Formulations (India) Limited

Particulars	Details
Live Share Price NSE India	INR 18.78
Previous Closing Price	INR 18.41
Open Price	INR 18.40
High	INR 19.05
Low	INR 18.16

Today BSE Share Price

Syncom Formulations (India) Limited

Particulars	Details
Live Share Price BSE India	INR 18.78
Previous Closing Price	INR 18.41
Open Price	INR 18.40
High	INR 19.05
Low	INR 18.16

Syncom Formulations (India) Limited

Leveraging accredited manufacturing facilities compliant with WHO-GMP standards, Syncom Formulations caters to government supply contracts, private institutions, and export markets, aligning its product pipeline with prevailing healthcare needs and evolving regulatory norms. The company’s integrated approach covers R&D, formulation, and large-scale production, positioning Syncom as a recognized supplier to national and international health agencies.

Frequently Asked Questions – StockYaari Stock Page

Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.

Final Thoughts

Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.